I-020201

· Kuros Biosurgery AG

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for I-020201, covering 2012-03-16 to 2012-03-16. Get the full timeline:

Most recent: Clinical Trial Update: A Dose Finding Study of Topically Applied I-020201 as an Adjunct to Good Standard-of-care in Patients With Chronic Diabetic Foot Ulcers [Phase 2]

See pricing